Melanoma Research Alliance Foundation
- Assets
- $27.3m
- Revenue
- $11.6m
- Investments
- $0.0
- Employees
- 17
- Location
- Washington, DC
- Founding
- 01/2009
- Data as of
- 12/2022
- EIN
- 26-1636099
Organization Overview
Melanoma Research Alliance Foundation is located in Washington, DC. The organization was established in 2009. According to its NTEE Classification (G11) the organization is classified as: Single Organization Support, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2022, Melanoma Research Alliance Foundation employed 17 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Melanoma Research Alliance Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Melanoma Research Alliance Foundation generated $11.6m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 0.3% each year. All expenses for the organization totaled $15.7m during the year ending 12/2022. While expenses have increased by 5.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Melanoma Research Alliance Foundation has awarded 248 individual grants totaling $83,237,506. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, SELECTED THROUGH A PEER-REVIEW PANEL AND INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO PREVENT, DETECT AND TREAT MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO MORE EFFECTIVE PREVENTION, EARLIER DETECTION AND BETTER TREATMENTS FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC AND FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY.
THE MRA OPERATES A PATIENT ENGAGEMENT PROGRAM THAT SUPPORTS INCREASED AWARENESS OF MELANOMA IN GENERAL, AND OF PREVENTION, DETECTION AND TREATMENT OPTIONS SPECIFICALLY. THE PATIENT ENGAGEMENT PROGRAM ALSO PROVIDES EDUCATION ABOUT AND PROMOTION OF CLINICAL TRIALS. THE PATIENT ENGAGEMENT PROGRAM INCLUDES DEVELOPMENT AND DISTRIBUTION OF EDUCATIONAL MATERIALS, THE PROVISION OF EDUCATIONAL FORUMS, A CLINICAL TRIAL NAVIGATOR FOR PATIENTS AND AN ON-LINE PATIENT COMMUNITY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Debra Black Chair/co-Founder | OfficerTrustee | 10 | $0 |
Margaret Anderson Thru 322 Director/secretary | OfficerTrustee | 0.5 | $0 |
Evan Bayh Started 322 Director/secretary | OfficerTrustee | 0.5 | $0 |
Leon Black Director/co-Founder | Trustee | 0.3 | $0 |
Suzanne Topalian Director | Trustee | 1 | $0 |
Michael Klowden Director | Trustee | 0.3 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $2,948,764 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $8,642,255 |
| Noncash contributions included in lines 1a–1f | $297,530 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $11,591,019 |
| Total Program Service Revenue | $0 |
| Investment income | $320,977 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$297,357 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $11,614,639 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $9,324,708 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $2,632,944 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,231,894 |
| Compensation of current officers, directors, key employees. | $172,465 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $638,310 |
| Pension plan accruals and contributions | $20,251 |
| Other employee benefits | $49,686 |
| Payroll taxes | $109,619 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $102,786 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $23,698 |
| Fees for services: Other | $237,967 |
| Advertising and promotion | $22,669 |
| Office expenses | $108,573 |
| Information technology | $215,789 |
| Royalties | $0 |
| Occupancy | $112,760 |
| Travel | $399,336 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $251,723 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $28,472 |
| All other expenses | $8,050 |
| Total functional expenses | $15,668,313 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,855,225 |
| Savings and temporary cash investments | $15,526,890 |
| Pledges and grants receivable | $5,454,387 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $54,192 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $4,407,652 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $35,000 |
| Total assets | $27,333,346 |
| Accounts payable and accrued expenses | $133,430 |
| Grants payable | $13,069,601 |
| Deferred revenue | $277,500 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $13,480,531 |
| Net assets without donor restrictions | $12,027,815 |
| Net assets with donor restrictions | $1,825,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $27,333,346 |
Grants Awarded
Over the last fiscal year, Melanoma Research Alliance Foundation has awarded $9,324,708 in support to 20 organizations.
| Grant Recipient | Amount |
|---|---|
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PURPOSE: PILOT AWARD | $100,000 |
TRUSTEES OF BOSTON UNIVERSITY PURPOSE: DERMATOLOGY FELLOWS AWARD | $35,000 |
THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL HOSPITAL PURPOSE: 1 YOUNG INVESTIGATOR AWARD, 1 TEAM SCIENCE AWARD, 1 DERMATOLOGY FELLOWS AWARD | $1,190,000 |
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC PURPOSE: 1 PILOT AWARD, 1 YOUNG INVESTIGATOR AWARD | $355,000 |
PRESIDENT AND FELLOWS OF HARVARD COLLEGE PURPOSE: TEAM SCIENCE AWARD | $600,000 |
JOHNS HOPKINS UNIVERSITY PURPOSE: TEAM SCIENCE ACADEMIC-INDUSTRY PARTNERSHIP AWARD | $899,999 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Melanoma Research Alliance Foundation Washington, DC | $27,333,346 | $11,614,639 |
Curesearch For Childrens Cancer Bethseda, MD | $8,001,953 | $6,131,955 |
Itineris Foundation Baltimore, MD | $4,487,386 | $971,447 |
Ovarian Cancer National Alliance Washington, DC | $1,318,025 | $1,732,411 |
Sarnoff Cardiovascular Research Foundation Inc Mclean, VA | $46,760,826 | $2,025,286 |
American Podiatric Medical Assoc Educational Foundation Inc Rockville, MD | $8,608,142 | $564,800 |
Nolan Robison Foundation Inc Lutherville Timonium, MD | $277,478 | $247,845 |
Snis Foundation Fairfax, VA | $674,412 | $136,779 |
Arlington County Medical Society Foundation Arlington, VA | $82,058 | $0 |
Inteleos Ultrasound Foundation Inc Rockville, MD | $0 | $0 |
Bay Aging Foundation Urbanna, VA | $1,061,969 | $217,684 |
Myra Dean Charitable Tr Uw 070281 Fbo Elderly Dorchester County Cambridge, MD | $87,492 | $157 |
Brave Dave Open Inc Kensington, MD | $6,105 | $0 |
American Kidney Fund Service Organization Rockville, MD | $0 | $0 |